Priority Date: 06.07.07 (US 20070948213P)

Derivatives of 1-(hetero)arylpyrazin-2-one useful for the treatment of diabetes, obesitas and related diseases

  • Application ID: EP08772437
  • Status: The application is deemed to be withdrawn

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna reitstotter kinzebach and partner
operating since 1928
Headquarter in Munich, Berlin and 1 office
active in Legal Services

Specialization

This EP application has the IPC class C07 (ORGANIC CHEMISTRY). Reitstötter Kinzebach & Partner GbR is specialized in C07. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 06.07.2007 - Priority Date (US 20070948213P)
  • 15.01.2009 - Publication A2 (WO2009009501)
  • 14.04.2010 - Publication A2 (EP2173725)

IPC Classification